Literature DB >> 2448680

Characteristics of an established human glioma cell line, KNS-42.

I Takeshita, T Takaki, M Kuramitsu, S Nagasaka, T Machi, H Ogawa, H Egami, H Mannoji, M Fukui, K Kitamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2448680     DOI： 10.2176/nmc.27.581

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN： 0470-8105            Impact factor:   1.742


× No keyword cloud information.
  12 in total

1.  ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.

Authors:  Ulf D Kahlert; Abigail K Suwala; Eric H Raabe; Florian A Siebzehnrubl; Maria J Suarez; Brent A Orr; Eli E Bar; Jaroslaw Maciaczyk; Charles G Eberhart
Journal:  Brain Pathol       Date:  2015-02-08       Impact factor: 6.508

2.  Improved technique for establishing short term human brain tumor cultures.

Authors:  M A Farr-Jones; I F Parney; K C Petruk
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Differential expression of glial fibrillary acidic protein in human glioma cell lines.

Authors:  A Nishiyama; K Onda; K Washiyama; T Kumanishi; R Kuwano; K Sakimura; Y Takahashi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; W A Franklin; H G Morse; E B Spector; K O Lillehei
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

5.  Contrary effect of lactic acid on expression of neuron-specific enolase and glial fibrillary acidic protein in human glioma cells.

Authors:  I Takeshita; H Sawa; T Nakamura; M Kuramitsu; K Kitamura; M Fukui
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.

Authors:  Carl Koschmann; Daniel Zamler; Alan MacKay; Dan Robinson; Yi-Mi Wu; Robert Doherty; Bernard Marini; Dustin Tran; Hugh Garton; Karin Muraszko; Patricia Robertson; Marcia Leonard; Lili Zhao; Dale Bixby; Luke Peterson; Sandra Camelo-Piragua; Chris Jones; Rajen Mody; Pedro R Lowenstein; Maria G Castro
Journal:  Oncotarget       Date:  2016-10-04

7.  Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.

Authors:  Hiroaki Katagi; Nozomu Takata; Yuki Aoi; Yongzhan Zhang; Emily J Rendleman; Gavin T Blyth; Frank D Eckerdt; Yusuke Tomita; Takahiro Sasaki; Amanda M Saratsis; Akihide Kondo; Stewart Goldman; Oren J Becher; Edwin Smith; Lihua Zou; Ali Shilatifard; Rintaro Hashizume
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

8.  High-throughput microRNA profiling of pediatric high-grade gliomas.

Authors:  Evelina Miele; Francesca Romana Buttarelli; Antonella Arcella; Federica Begalli; Neha Garg; Marianna Silvano; Agnese Po; Caterina Baldi; Giuseppe Carissimo; Manila Antonelli; Gian Paolo Spinelli; Carlo Capalbo; Vittoria Donofrio; Isabella Morra; Paolo Nozza; Alberto Gulino; Felice Giangaspero; Elisabetta Ferretti
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

9.  Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.

Authors:  Nada M S Al-Saffar; Lynley V Marshall; L Elizabeth Jackson; Geetha Balarajah; Thomas R Eykyn; Alice Agliano; Paul A Clarke; Chris Jones; Paul Workman; Andrew D J Pearson; Martin O Leach
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.

Authors:  Rafael Josupeit; Sebastian Bender; Sonja Kern; Barbara Leuchs; Thomas Hielscher; Christel Herold-Mende; Jörg R Schlehofer; Christiane Dinsart; Olaf Witt; Jean Rommelaere; Jeannine Lacroix
Journal:  Viruses       Date:  2016-05-19       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.